2 Patents
- US124420462025Method for Identifying a Shared Neoantigen-reactive T Cell Receptor
NEXCALIBUR THERAPEUTICS, Corp.
0 cites - US122779972025Rapid, Comprehensive and Sensitive Method for Neoantigen Screening from Recurrent Cancer Mutations
NEXCALIBUR THERAPEUTICS, Corp.
0 cites